Topical treatments for the prevention of radiodermatitis in cancer patients: a scoping review protocol
PDF
PDF (Português (Brasil))
HTML
HTML (Português (Brasil))
EPUB
EPUB (Português (Brasil))

Supplementary Files

AUDIO
AUDIO (Português (Brasil))

Keywords

Radiodermatitis
Neoplasms
Disease Prevention Radiodermatite
Neoplasias
Prevenção de Doenças

PlumX Metrics

Abstract

Objective: To map the available evidence on topical treatments used to prevent radiodermatitis in cancer patients. Method: Scoping review protocol developed following the Joanna Briggs Institute (JBI) methodology. The search strategy is subdivided into three steps using the MEDLINE, CINAHL, LILACS, Web of Science (WoS), and grey literature databases (theses, dissertations, guidelines, expert opinions, and promotional material from companies that own specific products), with no language or time restriction. Two independent reviewers will select articles, and data extraction will take place through a form built for this purpose. The extracted data will be presented in diagrams or tables, aligned with the objective of this scoping review, closing with a narrative synthesis.

https://doi.org/10.17665/1676-4285.20236637
PDF
PDF (Português (Brasil))
HTML
HTML (Português (Brasil))
EPUB
EPUB (Português (Brasil))

References

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. https://doi.org/10.3322/caac.21492

Instituto Nacional de Câncer José Gomes da Silva. Estimativa 2020: incidência de câncer no Brasil [Internet]. Rio de Janeiro: INCA; 2019 [cited 2020 Nov 04]. Available from: https://www.inca.gov.br/publicacoes/livros/estimativa-2020-incidencia-de-cancer-no-brasil

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209-49. https://doi.org/10.3322/caac.21660

Seité S, Bensadoun RJ, Mazer JM. Prevention and treatment of acute and chronic radiodermatitis. Breast Cancer (Dove Med Press). 2017;2017(9):551-57. https://doi.org/10.2147/BCTT.S149752

Hospital Israelita Albert Einstein. Radioterapia [Internet]. São Paulo: Hospital Israelita Albert Einstein; 2020 [cited 2020 Dez 04]. Available from: https://www.einstein.br/especialidades/oncologia/exames-tratamentos/radioterapia

Bontempo PSM, Ciol MA, Menêses AG, Simino GPR, Ferreira EB, Reis PED. Acute radiodermatitis in cancer patients: incidence and severity estimates. Rev Esc Enferm USP. 2021;55:e03676. https://doi.org/10.1590/S1980-220X2019021703676

Bontempo PSM. Ocorrência de radiodermatite em pacientes com câncer em um hospital de ensino de Brasília [dissertação de mestrado na Internet]. Brasília: Universidade de Brasília; 2017 [cited 2021 Jun 05]. 79 p. Available from: https://repositorio.unb.br/handle/10482/24844

Fernández-Castro M, Martín-Gil B. Efectividad del tratamiento tópico en pacientes com cáncer de mama que sufren radio dermatitis. una revisión sistemática. Enferm Clín (Ed impr). 2015;25(6):327-43. https://doi.org/10.1016/j.enfcli.2015.06.003

Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC). Int J Radiatoncol Biol Phys. 1995;31(5):1341–6. https://doi.org/10.1016/0360-3016(95)00060-C

Ginex PK, Backler C, Croson E, Horrell LN, Moriarty KA, Maloney C, et al. Radiodermatitis in patients with cancer: systematic review and meta-analysis. Oncol Nurs Forum. 2020;47(6):E225-E236. https://doi.org/10.1188/20.ONF.E225-E236

Ahn S, Sung K, Kim HJ, Choi YE, Lee YK, Kim JS, et al. Reducing radiation dermatitis using a film-forming silicone gel during breast radiotherapy: a pilot randomized-controlled trial. In Vivo. 2020;34(1):413-22.: https://doi.org/10.21873/invivo.11790

Costa CC, Lyra JS, Nakamura RA, Sousa CM. Radiodermatitis: analysis of predictive factors in breast cancer patients. Rev Bras Cancerol. 2019;65(1):e-05275. https://doi.org/10.32635/2176-9745.RBC.2019v65n1.275

Peters MD, Godfrey C, McInerney P, Munn Z, Tricco AC, Khalil H. Chapter 11: scoping reviews. In: Aromataris E, Munn Z, editors. JBI Manual of Evidence Synthesis [Internet]. Adelaide: JBI; 2020 [cited 2020 Jun 04]. Available from: https://synthesismanual.jbi.global. https://doi.org/10.46658/JBIMES-20-01

Tricco AC, Lilie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467-73. https://doi.org/10.7326/M18-0850

Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan - a web and mobile app for systematic reviews. Syst Rev. 2016;5(210):1-10. https://doi.org/10.1186/s13643-016-0384-4

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2023 Array